SCHEMBL7703310

SCHEMBL7703310

CN(Cc1ccccc1)C[C@H]1CCc2cc(O)ccc2[C@H]1c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 1/20 0.56
ESR1 P03372 6/20 0.44
ESR2 Q92731 6/20 0.44
STS P08842 1/20 0.44
HSD17B1 P14061 1/20 0.44
DRD2 P14416 2/20 0.42
DRD3 P35462 2/20 0.42
MLNR O43193 1/20 0.42
NR1I2 O75469 1/20 0.42
NR3C1 P04150 1/20 0.42
CHRM2 P08172 1/20 0.42
ADRB1 P08588 1/20 0.42
ADRA2A P08913 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
CHRM1 P11229 1/20 0.42
ADRA2B P18089 1/20 0.42
ADRA2C P18825 1/20 0.42
CHRM3 P20309 1/20 0.42
SLC6A2 P23975 1/20 0.42
NPY1R P25929 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7702711 1.00 SLC6A9 (0.56) SLC6A9ESR1ESR2STSHSD17B1
SCHEMBL7700451 0.86 SLC6A9 (0.53) SLC6A9HTR2AHTR2CSLC6A4OPRK1
SCHEMBL7700452 0.86 SLC6A9 (0.53) SLC6A9HTR2AHTR2CSLC6A4OPRK1
SCHEMBL7701273 0.84 SLC6A9 (0.60) SLC6A9HRH1HRH3
SCHEMBL7703437 0.84 SLC6A9 (0.60) SLC6A9HRH1HRH3
SCHEMBL7704292 0.84 SLC6A9 (0.75) SLC6A9
SCHEMBL7700175 0.84 SLC6A9 (0.75) SLC6A9
SCHEMBL7698359 0.83 SLC6A4 (0.55) SLC6A9DRD2DRD3SLC6A2SLC6A4
SCHEMBL7703450 0.80 SLC6A9 (0.48) SLC6A9SLC6A4MTNR1AMTNR1B
SCHEMBL7703453 0.80 SLC6A9 (0.48) SLC6A9SLC6A4MTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100769-B1 AMINOMETHYLCARBOXYLIC ACID DERIVATIVES AKZO NOBEL NV (NL) 2002-12-04 EP disclosed
US-6410592-B1 THERAPY FOR CENTRAL NERVOUS SYSTEM DISORDERS, PSYCHOLOGICAL DISORDERS AKZO NOBEL N.V. (NL) 2002-06-25 US disclosed